J&J sues former employee for allegedly taking thousands of documents to a new job at Pfizer; Immuno-oncology startup launches with $150 million

Taking stock of the drug industry, from the lab to the medicine chest

March 20, 2024 Check out STAT+

Sponsored By

By Ed Silverman Pharmalot Columnist, Senior Writer

Adobe STAT+ | J&J sues former employee for allegedly taking thousands of documents to a new job at Pfizer In a new lawsuit, the health care giant said Andrew Brackbill downloaded files containing 10-year business plans across different therapeutic areas. By Ed Silverman STAT+ | Immuno-oncology startup launches with $150 million, ex-Surface, Bluebird exec as CEO Clasp is working on a new type of T-cell engager developed by Johns Hopkins researchers Bert Vogelstein and Drew Pardoll. By Allison DeAngelis STAT+ | New gene therapy, to be priced at $4.25 million, has already transformed children's lives The world's most expensive treatment offers a near-cure for young children and redemption for its developer, but steep challenges still loom. By Jason Mast and Megan Molteni

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Pharmalot? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser